BKV CEO granted 62,197 restricted stock units

Kalnin Christopher P reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/12/2026 - 02:09 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Kalnin Christopher P reported acquisition or exercise transactions in this Form 4 filing.

BKV Corp reported that Chief Executive Officer Christopher P. Kalnin received an equity award of 62,197 shares of common stock in the form of restricted stock units under the BKV Corporation 2024 Equity and Incentive Compensation Plan.

These restricted stock units vest in three equal annual installments beginning on March 10, 2027, with each unit representing a contingent right to receive one share of common stock. Following this grant, Kalnin directly holds 1,297,243 shares, and a separate indirect holding of 875,754 shares is reported as owned by his spouse.

Insider Trade Summary

Grant/Award: 62,197 shares

Grant/Award 1 txn

Insider Kalnin Christopher P

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	62,197	$0.00	$0.00
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,297,243 shares (Direct); Common Stock — 875,754 shares (Indirect, By Spouse)

Holdings Before and After: Common Stock, 1,235,046 to 1,297,243 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BKV (BKV) disclose for CEO Christopher P. Kalnin?

BKV reported an equity award to its CEO. Christopher P. Kalnin received 62,197 restricted stock units of BKV common stock, granted at no cash cost, under the company’s 2024 Equity and Incentive Compensation Plan as part of his compensation package.

How do the new restricted stock units for BKV’s CEO vest?

The restricted stock units vest over three years. They vest in three equal annual installments beginning on March 10, 2027. Each unit represents a contingent right to receive one share of BKV common stock upon vesting, subject to plan terms.

How many BKV shares does CEO Christopher P. Kalnin hold after this Form 4?

Kalnin’s direct holdings total 1,297,243 shares. The filing also reports an additional 875,754 BKV shares held indirectly through his spouse, reflecting a separate ownership line item distinct from his direct position.

What does each restricted stock unit granted to BKV’s CEO represent?

Each unit represents one potential BKV common share. Specifically, each restricted stock unit is a contingent right to receive one share of BKV common stock, par value $0.01 per share, if and when the unit vests under the plan.

Is the BKV CEO’s Form 4 transaction an open-market stock purchase or sale?

The reported transaction is a stock grant, not a market trade. The Form 4 shows an award of 62,197 restricted stock units at a price of $0.00 per share, reflecting compensation rather than an open-market buy or sell.

What equity plan was used for the BKV CEO’s recent stock award?

The award was granted under BKV’s 2024 equity plan. The restricted stock units were issued pursuant to the BKV Corporation 2024 Equity and Incentive Compensation Plan, which governs vesting terms and the delivery of common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalnin Christopher P

(Last) (First) (Middle)

1200 17TH STREET, SUITE 2100

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BKV Corp [ BKV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A		62,197(1)	A	$0	1,297,243	D
Common Stock								875,754	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.

Remarks:

	/s/ Kathleen Lenox, attorney-in-fact	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.